Valuation: Merck KGaA

Market Cap 60.87B 70.25B 57.03B 52.02B 97.8B 0 99.3B 0 0 0 0 258B 0 P/E 2026 *
24x
P/E 2027 * 20.5x
Enterprise Value 68.54B 79.11B 64.22B 58.57B 110B 0 112B 0 0 0 0 291B 0 EV / Sales 2026 *
3.21x
EV / Sales 2027 * 2.97x
Free-Float
29.73%
Yield 2026 *
1.68%
Yield 2027 * 1.74%
1 day-0.64%
1 week-3.89%
Current month-2.55%
1 month-0.25%
3 months+15.15%
6 months+9.15%
Current year+13.78%
1 week 138.7
Extreme 138.7
146.3
1 month 130.1
Extreme 130.1
148.8
Current year 100.7
Extreme 100.7
148.8
1 year 100.7
Extreme 100.7
148.8
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 60 2026-04-30
Director of Finance/CFO 56 2023-06-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2019-04-25
Director/Board Member 59 2014-05-08
Director/Board Member 49 2020-05-27
Date Insider Type Main position Quantity % Market Cap.
3/27/25 Buy 1,401 0.0011%
3/27/25 Buy

Chief Executive Officer

2,341 0.0018%
3/27/25 Buy

Executive/Senior Manager

4,507 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-3.89%+25.62%-14.18% 70.25B
+1.41%+4.99%+62.94%+23.74% 328B
-1.77%+16.66%+53.61%+128.10% 11.55B
+0.79%+6.44%-0.29%-2.08% 8.52B
-0.68%+6.83%-11.34%-7.50% 4.88B
-0.72%+9.85%-25.68%+14.43% 4.37B
+1.29%+14.90%+4.22%+49.99% 4.22B
-1.21%+1.55%+11.36%+51.37% 2.78B
-0.28%-0.43%-2.07%-1.42% 2.24B
+1.73%+13.97%-13.42%+50.07% 2.01B
Average 0.00%+3.56%+10.50%+29.25% 43.88B
Weighted average by Cap. +0.94%+2.86%+52.21%+19.90%

Financials

2026 *2027 *
Net sales 21.35B 24.64B 20B 18.24B 34.3B 0 34.82B 0 0 0 0 90.5B 0 22.44B 25.9B 21.02B 19.17B 36.05B 0 36.6B 0 0 0 0 95.12B 0
Net income 2.52B 2.91B 2.36B 2.16B 4.05B 0 4.12B 0 0 0 0 10.7B 0 2.92B 3.36B 2.73B 2.49B 4.68B 0 4.76B 0 0 0 0 12.36B 0
Net Debt 7.67B 8.85B 7.19B 6.56B 12.33B 0 12.52B 0 0 0 0 32.52B 0 5.76B 6.65B 5.4B 4.92B 9.26B 0 9.4B 0 0 0 0 24.43B 0
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
62,136
Date Price Change Volume
26-08-13 139.50 -0.36% 160,881
26-08-12 €140.00 0.00% 226,564
26-08-11 €140.00 -2.44% 240,780
26-08-10 €143.50 -0.10% 198,448
26-08-07 €143.65 -1.03% 296,823
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
140.00EUR
Average target price
151.14EUR
Spread / Average Target
+7.96%

Quarterly revenue - Rate of surprise